Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03425279
Title CAB-AXL-ADC Safety and Efficacy Study in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioAtla, LLC
Indications

melanoma

lung non-small cell carcinoma

Advanced Solid Tumor

pancreatic ductal adenocarcinoma

Therapies

CAB-AXL-ADC

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.